Edition:
United States

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

2.65USD
17 Aug 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.65
Open
$2.59
Day's High
$2.69
Day's Low
$2.58
Volume
46,008
Avg. Vol
34,546
52-wk High
$4.56
52-wk Low
$2.55

Chart for

About

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the... (more)
No analyst recommendations are available for .

Overall

Beta: 0.50
Market Cap(Mil.): $151.20
Shares Outstanding(Mil.): 57.06
Dividend: --
Yield (%): --

Financials

  NYMX.OQ Industry Sector
P/E (TTM): -- 99.36 30.45
EPS (TTM): -0.23 -- --
ROI: -745.47 2.89 12.63
ROE: -917.44 1.65 14.82

Earnings vs. Estimates